1 / 15

Research Report on In Vitro Diagnostics Technologies and Global Markets

bharatbookseo
Download Presentation

Research Report on In Vitro Diagnostics Technologies and Global Markets

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Research Report on In Vitro Diagnostics Technologies and Global Markets

  2. The global market for in vitro diagnostics (IVD) products was totaled at $57.3 billion in 2014. It is expected to grow from $60.3 billion in 2015 to $81.1 billion by 2020 at a compound annual growth rate (CAGR) of 6.1% from 2015 to 2020. This report provides: -An overview of the global markets and related technologies for in vitro diagnostics -Analyses of global market trends, with data from 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020 -Detailed coverage of application areas, end users, and factors influencing and inhibiting demand for IVD Information about IVD products including reagents, instruments, and data management softwares and services

  3. -A look at how the rise in the number of diseases like respiratory infections, hospital acquired infections (HAI), and sexually transmitted diseases are creating a constant need for infectious disease testing both in hospitals and laboratories -Segmentation into immunochemistry, clinical chemistry, SMBG, POC, MDx, hematology, microbiology, hemostasis and tissue diagnostics -Geographical breakdowns -Application analysis: Diabetes, infectious, oncology, cardiology, neurology and others. -Profiles of major players in the industry

  4. INTRODUCTION STUDY GOALS AND OBJECTIVES This report offers a comprehensive analysis of the global in-vitro diagnostic market, along with an in-depth study of the various IVD segments (clinical chemistry, immunoassays, point-of-care diagnostics, molecular diagnostics, hematology, microbiology and tissue diagnostics); products (instruments, reagents and accessory products); end-user groups (central labs, critical care, OTC/self-testing and academia); and the regional markets of North America, Europe, Asia and LAAM (Latin America/Africa/Middle East).

  5. This report provides a complete review and analysis of the current trends in the IVD markets, along with industry growth drivers and restraints. Revenues are broken down by regions, segments, products and end users, and sales figures have been estimated for the five-year period from 2015 through 2020 in constant U.S. dollars. In addition, it provides an examination and description of select products, current and emerging technologies, and company profiles. Applications for IVD are also discussed, with emphasis of the use of these types of tests in various disease sectors. Further, the report offers a view on IVD patents, regulatory aspects and emerging developments in the IVD market across the globe.

  6. REASONS FOR DOING THIS STUDY In vitro diagnostic tests performed on biological samples, such as blood, urine, saliva, spinal fluid and DNA, are a key component of health care delivery. The information provided by IVD tests enable medical care providers to manage several diseases through timely prevention, diagnosis and decision making, and by administering patient-specific treatment modalities. Due to recent rapid technological advances and automation, the range and complexity of diagnostic tests have overwhelmingly increased. This has made lab tests much easier to use and less error prone, with more precise and timelier results, thus transforming medical practice.

  7. As a result of these rapid innovations, disease detection has been made possible much before the appearance of symptoms, along with the prediction of beneficial and adverse treatment outcomes. These developments have in turn enabled personalized treatment through the emergence of point-of-care (POC) tests and home-based testing in the form of blood glucose meters for diabetics, pregnancy tests and cholesterol tests. These tests facilitate more rapid decision-making, especially for management of major chronic diseases such as diabetes, hypertension or cardiovascular conditions. Instead of a patient having to wait for test results and schedule his or her next visit, test values for key biochemical parameters (such as, for example, HbA1c or lipid profiles), are generated the same day, allowing a doctor to make treatment decisions during the same visit.

  8. In addition, new tests have become less invasive, easier to perform and more patient friendly. Likewise, for critical care, POC tests enable doctors to make life-saving decisions within minutes, as opposed to waiting for hours for test data that was once available only from a central lab. Today, more than 4,000 different diagnostic tests have become available, and as more IVD tests become compatible with POC environments, health care providers should take advantage of the benefits of these evolving IVDs for effective treatment of life-threatening illnesses through optimization of healthcare delivery. IVDs have already tremendously impacted cancer diagnosis and treatment globally by gaining deeper insights into genetic pathways of the disease enabled by human genome sequencing. As a result, identifying faulty genes, personalized risk predictions and tailored therapies have now become possible.

  9. Big challenges need to be addressed, however, despite IVDs being at the top of global market attractiveness index. The regional and country-wise differences in regulatory aspects, market approvals and entry bottlenecks, affordability issues, reimbursement inadequacies, logistics and healthcare infrastructure may hold the market back. Due to these factors, the IVD companies need to look at each country’s market landscape and IVD requirements, and then tailor their entries, launch and marketing strategies to gain a strong foot hold. This BCC Research report, In Vitro Diagnostics: Technologies and Global Markets, will thereby provide a detailed analysis of these and other key factors governing the growth of IVD industry, and provide strategic insights and recommendations for those looking to expand their markets.

  10. CONTRIBUTION OF THE STUDY AND FOR WHOM The intended audience includes all the stakeholders of the IVD market: diagnostic test manufacturing companies, disposable vendors, reagent suppliers, start-ups, technology and business incubators, venture capital firms, hospitals, diagnostic labs, physician offices and groups, university research groups and other involved participants. With its broad scope and in-depth analyses, this study is a valuable resource to anyone involved with or interested in the development and promotion of IVD technologies. Since this study provides business and technical information of a timely nature, it will prove valuable to a variety of readers, including industry executives, managers and planners, purchasers, industry analysts and investors. The projections, forecasts and trend analyses found in this report provide readers with the necessary data and information for careful decision-making and products that will best meet the needs of the IVD segment.

  11. SCOPE OF REPORT The scope of this study is global. This Report on analyzes each market and its applications, regulatory environment, technologies involved, market projections and market shares. The emerging markets discussed include countries such as India, China, Korea, Taiwan, Africa, Australia, Brazil and Russia, among others. The report also examines the IVD market drivers as well as restraints and challenges affecting its growth. Further, the report also highlights the emerging products and technologies and associated start-ups that are likely to accelerate the growth of the IVD industry through their best practices in the research and development of IVDs. Excluded from this study are diagnostic testing such as imaging, veterinary diagnostics and their associated products.

  12. This study will provide information on these areas: -Structure and current market size of the IVD market as outlined with forecasts through 2020. -Impact of chronic diseases, growing and aging populations. -Current technology and product suppliers and key innovations. -A look at the IVD industry and trends affecting the market. -Markets by each segment (immunochemistry, molecular diagnostics, POC tests, clinical microbiology, hematology and tissue diagnostics) provide a global overview showing market data for the U.S., Europe, Asia and LAAM regions. -Emerging opportunities and potential investment opportunity areas for IVD. -Technology patent trends relating to IVD. -Profiles for more than 20 companies in the industry with significant contributions and market shares.

  13. METHODOLOGY Information for this report was derived from a variety of primary and secondary research sources, including industry analysts, annual reports and Securities and Exchange Commission (SEC) reports, the United Network for Organ Sharing (UNOS), the Organ Procurement and Transplantation Network (OPTN), the Scientific Registry of Transplant Recipients (SRTR), the Center for Medicare and Medicaid Services (CMS), the National Institutes of Health (NIH), the Centers for Disease Control (CDC), other government agencies and journal articles. Secondary sources include literature searches, product literature and press releases. When precise information was not available, a consensus was made using reasonable assumptions and estimates based on historical data. Data were collected through interviews and correspondence with IVD industry experts. Projections were based on estimates and information based on historical revenue trends in subsegments, validations through primary research, mergers and acquisitions, and market trends.

  14. Table of Contents • Introduction - Complimentary 4 $0 • Global Market Trends • Market Landscape • Global Ivd Market By Subcategories • Global Immunochemistry Market 8 $375 Applications • Global Poc Testing Market 8 $375 Applications • Global Hematology Market 7 $328 Applications • Global Molecular Diagnostics Market 13 $609 Applications • Global Clinical Microbiology Market 5 $234 Applications • Global Tissue Diagnostics Market 6 $281 Applications W : www.bharatbook.com , T :  +91 22 27810772, 27810773, E :  info@bharatbook.com

  15. To view the full Executive Summary and Table of Contents, please visit: Research Report on In Vitro Diagnostics Technologies and Global Markets Contact Us:-Call India: +91-22-27810772/73Email id : info@bharatbook.comWebsite :www.bharatbook.comOur Blog : https://www.bharatbook.com/blog/ W : www.bharatbook.com , T :  +91 22 27810772, 27810773, E :  info@bharatbook.com

More Related